Document is current
Any future updates will be listed below
-
Authors
Tezuka, Toshiki
Okuzumi, Shinichi
Nakashima, Chiho
Ide, Toshihiro
Imai, Shungo
Mitsuboshi, Satoru
Kuwahara, Yuki
Takizawa, Tsubasa
Seki, Morinobu
Minematsu, Naoto
Aragane, Naoko
Nakahara, Jin
Hori, Satoko
Nakane, Shunya
Suzuki, Shigeaki https://orcid.org/0000-0003-4388-4574
-
Funding
Funding for this research was provided by:
Japan Society for the Promotion of Science (JP20H03592)
- License Information
-
More Information
Article History
Received: 25 January 2023
Revised: 15 February 2023
Accepted: 14 March 2023
First Online: 20 March 2023
Declarations
:
: ToT, SO, CN, TI, SI, SM, YK, TsT, MS, NM, NA, JN, SH, and SN: declare no competing interests. SS: is a consultant/advisory board member on neurologic side effects for Ono Pharmaceutical, Bristol-Myers Squibb, MSD, Chugai, and Astra Zeneca. Outside of the submitted work, SS reports personal fees from Ono Pharmaceutical, Bristol-Myers Squibb, MSD, Chugai, and Astra Zeneca.
: This study was approved by the Ethics Committee for Human Research of the Keio University School of Medicine and was therefore performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. All the subjects gave their informed consent (#N20170237).
